nimodipine has been researched along with Eye Disorders in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ocular ischaemic syndrome is a progressive and serious vision-threatening condition that is usually associated with carotid artery disease, and poor effective therapeutic options are available." | 1.42 | Reversed ocular ischaemic syndrome secondary to carotid cavernous sinus embolisation. ( Branco, G; Costa, JM; Isidro, F; Reizinho, C, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isidro, F | 1 |
| Reizinho, C | 1 |
| Branco, G | 1 |
| Costa, JM | 1 |
1 other study available for nimodipine and Eye Disorders
| Article | Year |
|---|---|
Reversed ocular ischaemic syndrome secondary to carotid cavernous sinus embolisation.
Topics: Aged; Carotid Arteries; Carotid-Cavernous Sinus Fistula; Cavernous Sinus; Embolization, Therapeutic; | 2015 |